A 참고문헌

1. US FDA. Guidance for Industry - Population Pharmacokinetics, Feb. 1999.
2. European Medicines Agency, Guideline on Reporting the Results of Population Pharmacokinetic Analysis. Jun. 2007.
3. Beal SL, Sheiner LB. Estimating Population Pharmacokinetics. CRC Critical Rev Biomed Eng 1982;8:195-222.
4. Bonate PL. Pharmacokinetic-Pharmacodynamic Modeling and Simulation. 2e. Springer. 2011.
5. Ette EI, Williams PJ. Pharmacometrics: The Science of Quantitative Pharmacology. John Wiley & Sons Inc. 2007.
6. Gabrielsson J, Weiner D. Pharmacokinetic & Pharmacodynamic Data Analysis: Concepts and Applications. 4e. Swedish Pharmaceutical Press. 2000.
7. Sheiner LB. Learning vs Confirming in Clinical Drug Development, Clin Pharmacol Ther 1997; 61:275-291.
8. Karlsson MO. Diagnosing Model Diagnostics. Clinical Pharmacology & Therapeutics. 2007; 82:17-20.
9. Kevin Dykstra. Reporting guidelines for population pharmacokinetic analyses. J Pharmacokinet Pharmacodyn. 2015; 42:301-314.